IP Library Granted Patent US 8,728,518
Granted Patent B2
US 8,728,518 · App. 11/574,313 · Granted May 20, 2014

Butylphthalide self-emulsifying drug delivery system, its preparation and method and application

Inventors: Zhentao Liu (Hebei Province, CN); Liying Yang (Hebei Province, CN); Hanyu Yang (Hebei Province, CN); Yuqing Gao (Hebei Province, CN); Dongmin Shen (Hebei Province, CN); Wenmin Guo (Heibei Province, CN); Xiaolong Feng (Heibei Province, CN); Jia Zheng (Heibei Province, CN)
Assignee: CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,728,518
App. No.
11/574,313
Granted
May 20, 2014
Kind
B2
Abstract

The present invention relates to a novel drug delivery and release system, i.e. Self-emulsifying Drug Delivery System (SEDDS), of butylphthalide, to a preparation process thereof, and to a use thereof in a pharmaceutical formulation. The drug delivery system comprises as essential ingredients 1% to 65% of butylphthalide and 10% to 65% of a emulsifying agent, together with various excipients as required depending on the desired dosage forms. The present invention significantly increases the contact area between butylphthalide and the mucous membrane of the gastrointestinal tract, and therefore improves the absorptivity of the drug.

Claims (14)

1. A butylphthalide self-emulsifying drug delivery system, characterized in that it comprises by weight 25.3% to 65% of butylphthalide, 10% to 65% of an emulsifying agent, and 0% to 64.7% of an excipient, based on the weight of the self-emulsifying drug delivery system of butylphthalide.

2. The butylphthalide self-emulsifying drug delivery system according to claim 1 , comprising by weight 25.3% to 50% of butylphthalide, 15% to 60% of an emulsifying agent, and 5% to 59.7% of an excipient, based on the weight of the self-emulsifying drug delivery system of butylphthalide.

3. The self-emulsifying drug delivery system of butylphthalide according to claim 1 or 2 , wherein the butylphthalide is selected from the group consisting of its racemic, levo-rotary and dextro-rotary isoforms.

4. The butylphthalide self-emulsifying drug delivery system according to claim 1 or 2 , wherein the emulsifying agent is chosen from any one of the group consisting of: liquid or solid ethoxy polyoxyethylene glyceride, polyoxyethylene oleate, liquid lecithin, polyoxyethylene castor oil, coconut oil, polyethyleneglycol glyceride, almond oil oleate polyethyleneglycol glycerin ester, polyoxyethylene glycerin trioleate, polyoxyethylene sorbitan oleate, and polyethyleneglycol-8 glycerin caprylate/caprate, or the mixture of any two or more thereof.

5. The butylphthalide self-emulsifying drug delivery system according to claim 1 or 2 , further comprising water, a solubilizing agent and a flavoring.

6. The butylphthalide self-emulsifying drug delivery system according to claim 1 or 2 , wherein the excipient is selected from edible vegetable oils.

7. The butylphthalide self-emulsifying drug delivery system according to claim 6 , wherein the vegetable oils are selected from any one of the group consisting of sesame oil, corn oil, peanut oil, soybean oil, almond oil, peach kernel oil, cotton seed oil, sunflower seed oil, and olive oil, or the mixture of any two or more thereof.

8. The butylphthalide self-emulsifying drug delivery system according to claim 4 , wherein the emulsifying agent is the mixture of polyoxyethylene castor oil and polyethyleneglycol-8 glycerin caprylate/caprate at the ratio of 1:0.5 to 1.5 by weight.

9. The butylphthalide self-emulsifying drug delivery system according to claim 1 , wherein the self-emulsifying drug delivery system of butylphthalide is in the dosage form of oral liquid, soft capsule, hard capsule, delayed release capsule, oral solid powder or granule, tablet, or delayed release tablet.

10. A process for the preparation of the butylphthalide self-emulsifying drug delivery system of according to claim 1 , comprising completely melting and mixing the emulsifying agent in a water bath at 20 to 60° C., then adding butylphthalide with agitation and mixing, and adding the excipient, to prepare a dosage form according to the butylphthalide self-emulsifying drug delivery system.

11. The butylphthalide self-emulsifying drug delivery system according to claim 1 , wherein the weight ratio of butylphthalide to emulsifying agent is greater than or equal to 2:1.

12. The butylphthalide self-emulsifying drug delivery system according to claim 1 , wherein the weight ratio of butylphthalide to emulsifying agent is 2:1.

13. A butylphthalide self-emulsifying drug delivery system, characterized in that it comprises by weight 20% to 65% of butylphthalide, 10% to 65% of an emulsifying agent, and 0% to 70% of an excipient, based on the weight of the self-emulsifying drug delivery system of butylphthalide, wherein the weight ratio of butylphthalide to emulsifying agent is greater than or equal to 2:1.

14. The butylphthalide self-emulsifying drug delivery system according to claim 13 , wherein the weight ratio of butylphthalide to emulsifying agent is 2:1.

Assignments (2)
CHANGE OF NAME Recorded Aug 9, 2013
From: SHIJIAZHUANGPHARMA. GROUP ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
To: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
Reel/Frame 030994/0519 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2007
From: LIU, ZHENTAO; YANG, LIYING; YANG, HANYU; GAO, YUQING; SHEN, DONGMIN; GUO, WENMIN; FENG, XIAOLONG; ZHENG, JIA
To: SHIJIAZHUANG PHARMA, GROUP ZHONGOI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO. LTD.
Reel/Frame 019914/0468 →
Priority Claims (1)
CN 2004 1 0075068 · Aug 27, 2004 · national
Continuity (1)
Related Publication 20080319056A1 · Dec 25, 2008